French dairy giant Danone missed third-quarter sales expectations and lowered its full-year outlook, blaming the recall of infant formula in Asia sparked by Fonterra’s whey powder recall.
In a sales update released this morning (16 October), Danone missed like-for-like sales expectations in the quarter, with comparable sales up 4.2% compared to consensus expectations of 4.8%. Volumes and reported sales also missed expectations at 1.6% and 0% respectively, compared to consensus analyst forecasts of 3.6% and 2.8%.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The company said the sales softness was the result of the impact of the “false safety alert in Asia” which resulted in “significant losses in sales, earnings and cash-flow”.
Danone baby food on sale in China and New Zealand was pulled from shelves in August after Fonterra, a supplier of ingredients to the Dumex and Karicare brand owner, warned some of its whey protein concentrate contained a bacteria that could cause botulism. While it transpired the scare was a false alarm, Danone’s result was hit by the immediate impact of the recall.
The company also implied the damage done to Danone’s reputation was continuing to drag on sales, but emphasised it is working to gradually restore consumer confidence. “Action plans to restore sales are being deployed in affected markets and are generating results effectively but very gradually,” Danone said.
Danone and Fonterra are currently in a “dispute resolution process”, with the French group seeking damages after the recall.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataDanone reduced guidance for sales to 4.5%-5%, down from “at least” 5%. The company also lowered its margin outlook to -80 basis points, down from -30bps to -50bps.
Danone is the latest of the European food majors to issue a profit warning – following in the footsteps of both Nestle and Unilever.
